I think that's a reasonable question @ad0.I'd be inclined to...

I think that's a reasonable question @ad0.

I'd be inclined to agree with your suggestion that the latest CR is just "facilitating the (ultimate) recommissioning". The funds will help DDD to take another small step on the long & winding path that hopefully leads to plant recommissioning at some stage in the future.

I remember a few years back a different company needed to raise funds (for survival) & management worded things in the CR presentation as if the funds raised would be enough to get the proposed plant upgrade over the line. However, a few years later (plus quite a few more cap raises) & the latest take on the plant upgrade is that management are expecting commissioning to be completed sometime later in the year (but only if there aren't any more delays).

These things (i.e. future plant upgrades) usually take longer then expected for one reason or another. It'll be interesting to see if there's any life in the DDD share price when the Scoping Study (Part 2) is released. My expectations for SP improvement are mostly neutral but slightly positive (at this stage).